Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on effect of vinpocetine infusion to aspirin on hemorheology in chronic cerebrovascular disease
2008-001835-36Phase 4Completed
- Sponsor
- Gedeon Richter Plc
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of vinpocetine in cerebrovascular disease and Large Artery Atherosclerotic Stroke, sponsored by Gedeon Richter Plc. Primary endpoints: Exploratory hemorheological effect of vinpocetine add-on to aspirin and Safety and tolerability of vinpocetine infusion plus Aspirin Protect. Started May 2008; status: completed.
02
Drugs
vinpocetine
03
Conditions
cerebrovascular diseaseLarge Artery Atherosclerotic Stroke
Beyond the preview
Go deeper on 2008-001835-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001835-36.